These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32861031)

  • 41. Emerging Technologies for Cancer Research: Towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models.
    Turetta M; Ben FD; Brisotto G; Biscontin E; Bulfoni M; Cesselli D; Colombatti A; Scoles G; Gigli G; Del Mercato LL
    Curr Med Chem; 2018; 25(35):4616-4637. PubMed ID: 29874987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy.
    Pradhan S; Smith AM; Garson CJ; Hassani I; Seeto WJ; Pant K; Arnold RD; Prabhakarpandian B; Lipke EA
    Sci Rep; 2018 Feb; 8(1):3171. PubMed ID: 29453454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma.
    Mäkelä R; Arjonen A; Härmä V; Rintanen N; Paasonen L; Paprotka T; Rönsch K; Kuopio T; Kononen J; Rantala JK
    BMC Cancer; 2020 Jun; 20(1):590. PubMed ID: 32576176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway.
    Green R; Howell M; Khalil R; Nair R; Yan J; Foran E; Katiri S; Banerjee J; Singh M; Bharadwaj S; Mohapatra SS; Mohapatra S
    Sci Rep; 2019 Dec; 9(1):18177. PubMed ID: 31796785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment.
    Niu Y; Bai J; Kamm RD; Wang Y; Wang C
    Mol Pharm; 2014 Jul; 11(7):2022-9. PubMed ID: 24533867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tunable Collagen Microfluidic Platform to Study Nanoparticle Transport in the Tumor Microenvironment.
    DeWitt MR; Rylander MN
    Methods Mol Biol; 2018; 1831():159-178. PubMed ID: 30051431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.
    Ozcelikkale A; Moon HR; Linnes M; Han B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Organ-Tumor-on-a-Chip for Chemosensitivity Assay: A Critical Review.
    Kashaninejad N; Nikmaneshi MR; Moghadas H; Kiyoumarsi Oskouei A; Rismanian M; Barisam M; Saidi MS; Firoozabadi B
    Micromachines (Basel); 2016 Jul; 7(8):. PubMed ID: 30404302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On-chip anticancer drug screening - Recent progress in microfluidic platforms to address challenges in chemotherapy.
    Dhiman N; Kingshott P; Sumer H; Sharma CS; Rath SN
    Biosens Bioelectron; 2019 Jul; 137():236-254. PubMed ID: 31121461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
    Liu PF; Cao YW; Zhang SD; Zhao Y; Liu XG; Shi HQ; Hu KY; Zhu GQ; Ma B; Niu HT
    Oncotarget; 2015 Nov; 6(35):37695-705. PubMed ID: 26462177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Patient-derived tumor organoids (or tumoroid) as valuable precision medicine tools].
    Perréard M; Florent R; Thorel L; Vincent A; Weiswald LB; Poulain L
    Med Sci (Paris); 2022 Nov; 38(11):888-895. PubMed ID: 36448894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3D microfluidic tumor models for biomimetic engineering of glioma niche and detection of cell morphology, migration and phenotype change.
    Lin L; He Z; Jie M; Lin JM; Zhang J
    Talanta; 2021 Nov; 234():122702. PubMed ID: 34364499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models.
    Virumbrales-Muñoz M; Ayuso JM; Olave M; Monge R; de Miguel D; Martínez-Lostao L; Le Gac S; Doblare M; Ochoa I; Fernandez LJ
    Sci Rep; 2017 Sep; 7(1):11998. PubMed ID: 28931839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma.
    Zoetemelk M; Rausch M; Colin DJ; Dormond O; Nowak-Sliwinska P
    Sci Rep; 2019 May; 9(1):7103. PubMed ID: 31068603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
    Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
    Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microfluidic 3D models of cancer.
    Sung KE; Beebe DJ
    Adv Drug Deliv Rev; 2014 Dec; 79-80():68-78. PubMed ID: 25017040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surface Acoustic Waves (SAW)-Based Biosensing for Quantification of Cell Growth in 2D and 3D Cultures.
    Wang T; Green R; Nair RR; Howell M; Mohapatra S; Guldiken R; Mohapatra SS
    Sensors (Basel); 2015 Dec; 15(12):32045-55. PubMed ID: 26703604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved microfluidic platform for simultaneous multiple drug screening towards personalized treatment.
    Mitxelena-Iribarren O; Zabalo J; Arana S; Mujika M
    Biosens Bioelectron; 2019 Jan; 123():237-243. PubMed ID: 30224287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.